This is a $149,340.18 firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency to Genentech USA, Inc., a foreign-owned pharmaceutical manufacturer, for the supply of the antiviral drug oseltamivir phosphate (Tamiflu). The order was placed against Genentech's existing $27.9 million indefinite delivery contract with the Defense Logistics Agency to provide medical supplies and critical pharmaceuticals supporting the Department of Defense's global health logistics network. No set-aside designation was used for this award. Genentech also holds a $4.9 billion Federal Supply Schedule contract with the Department of Veterans Affairs to supply drugs, pharmaceuticals, and hematology products across the VA health system and affiliated agencies.